Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
argenx
ARGX
|
$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Prime Medicine
PRME
$606M
| $173K | ﹤0.01% |
+14,091
| New | +$173K |
|
2527
Definitive Healthcare
DH
$417M
| $172K | ﹤0.01% |
+16,660
| New | +$172K |
|
|
VLD
2528
DELISTED
Velo3D, Inc.
VLD
| $172K | ﹤0.01% |
+2,165
| New | +$172K |
|
2529
REV Group
REVG
$3B
| $171K | ﹤0.01% |
+14,254
| New | +$171K |
|
2530
Pennant Group
PNTG
$832M
| $171K | ﹤0.01% |
+11,954
| New | +$171K |
|
2531
Vanda Pharmaceuticals
VNDA
$274M
| $169K | ﹤0.01% |
24,908
+13,762
| +123% | +$93.4K |
|
2532
Stitch Fix
SFIX
$732M
| $168K | ﹤0.01% |
32,945
+20,705
| +169% | +$106K |
|
2533
TaskUs
TASK
$1.62B
| $167K | ﹤0.01% |
+11,582
| New | +$167K |
|
2534
Liquidity Services
LQDT
$841M
| $166K | ﹤0.01% |
+12,612
| New | +$166K |
|
|
TRTX
2535
TPG RE Finance Trust
TRTX
$747M
| $166K | ﹤0.01% |
22,833
+12,609
| +123% | +$91.5K |
|
2536
Babcock & Wilcox
BW
$221M
| $165K | ﹤0.01% |
27,312
+14,778
| +118% | +$89.5K |
|
2537
Aclaris Therapeutics
ACRS
$224M
| $165K | ﹤0.01% |
+20,389
| New | +$165K |
|
|
ROVR
2538
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $165K | ﹤0.01% |
36,447
+18,185
| +100% | +$82.1K |
|
2539
Westrock Coffee
WEST
$513M
| $163K | ﹤0.01% |
+13,350
| New | +$163K |
|
2540
Quanterix
QTRX
$201M
| $163K | ﹤0.01% |
+14,451
| New | +$163K |
|
|
ONL
2541
Orion Office REIT
ONL
$166M
| $162K | ﹤0.01% |
24,241
+13,379
| +123% | +$89.5K |
|
2542
Bridgewater Bancshares
BWB
$455M
| $161K | ﹤0.01% |
+14,838
| New | +$161K |
|
2543
Great Lakes Dredge & Dock
GLDD
$794M
| $160K | ﹤0.01% |
29,599
+16,375
| +124% | +$88.7K |
|
|
PTVE
2544
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $157K | ﹤0.01% |
+19,707
| New | +$157K |
|
2545
Oscar Health
OSCR
$4.75B
| $154K | ﹤0.01% |
23,550
+10,585
| +82% | +$69.2K |
|
|
NUTX
2546
Nutex Health
NUTX
$477M
| $152K | ﹤0.01% |
1,009
+519
| +106% | +$78.3K |
|
|
SWI
2547
DELISTED
SolarWinds Corporation Common Stock
SWI
| $152K | ﹤0.01% |
+17,668
| New | +$152K |
|
2548
MaxCyte
MXCT
$145M
| $152K | ﹤0.01% |
30,707
+17,096
| +126% | +$84.5K |
|
2549
Blink Charging
BLNK
$117M
| $151K | ﹤0.01% |
+17,537
| New | +$151K |
|
2550
Invesco Mortgage Capital
IVR
$529M
| $151K | ﹤0.01% |
+13,644
| New | +$151K |
|